Hydroxychloroquine (HCQ) in lupus pregnancy: Double-blind and placebo-controlled study

Lupus

Volumn 10, Issue 6, 2001, Pages 401-404

  Levy, R A ^a   Vilela, V S ^a   Cataldo, M J ^a   Ramos, R C ^a   Duarte, J L M B ^a   Tura, B R ^a   Albuquerque, E M N ^a   Jesus N R ^a  

^a HOSPITAL UNIVERSITÁRIO PEDRO ERNESTO   (Brazil)

Author keywords

Antimalarials; Hydroxychloroquine; Lupus pregnancy

Indexed keywords

ANTIMALARIAL AGENT; DNA ANTIBODY; DOUBLE STRANDED DNA; HYDROXYCHLOROQUINE; PLACEBO; PREDNISONE;

ADULT; APGAR SCORE; ARTHRITIS; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DELIVERY; DISCOID LUPUS ERYTHEMATOSUS; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG SAFETY; FEMALE; FETUS DEATH; HEMOLYTIC ANEMIA; HUMAN; HUMAN TISSUE; INFLAMMATION; LUPUS ERYTHEMATOSUS; NEUROLOGIC EXAMINATION; OPHTHALMOLOGY; PREGNANCY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RASH; SCORING SYSTEM; SKIN DEFECT; SYSTEMIC LUPUS ERYTHEMATOSUS; TOXEMIA; TREATMENT OUTCOME; UVEITIS;

ADULT; ANTIMALARIALS; DOUBLE-BLIND METHOD; FEMALE; HUMANS; HYDROXYCHLOROQUINE; LUPUS ERYTHEMATOSUS, SYSTEMIC; PLACEBOS; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY OUTCOME;

EID: 0034990187     PISSN: 09612033     EISSN: None     Source Type: Journal    
DOI: 10.1191/096120301678646137     Document Type: Article

References (25)

1. Increased rate of lupus flare during pregnancy and puerperium: A prospective study of 78 pregnancies
2. Frequency of lupus flare in pregnancy. The Hopkins Lupus Pregnancy Center experience
3. Antimalarial drugs in the treatment of rheumatological diseases
4. Anti-malarial drugs: Possible mechanisms of action in autoimmune disease and prospects for drug development
5. Therapy for systemic lupus erythematosus
6. Aspects of use of antimalarials in systemic lupus erythematosus
7. A randomized study of the effect of withdrawing hydroxychloroquine sulfate in systemic lupus erythematosus
8. A long-term study of hydroxychloroquine withdrawal on exacerbations in systemic lupus erythematosus
9. Hydroxychloroquine use in Baltimore Lupus Cohort: Effects on lipids, glucose and thrombosis
10. Antimalarial agents and lupus
11. The teratogenicity of antirheumatic drugs: What is the evidence?
12. Ototoxicity of chloroquine
13. Accumulation of chorioretinotoxic drugs in the foetal eye
14. A study of 100 high-risk pregnancies
15. Hydroxychloroquine in pregnant patients with systemic lupus erythematosus
16. Hydroxychloroquine and lupus pregnancy: Review of a series of 36 cases
17. Antimalarial drugs in pregnancy: The North American experience
18. Pregnancy outcome following first trimester exposure to chloroquine
19. Assessing disease activity in SLE patients during pregnancy
20. Antimalarials
21. Thrombosis and systemic lupus erythematosus: The Hopkins Lupus Cohort perspective
22. Hydroxychloroquine on prophylaxis of pulmonary embolism following hip artrhroplasty
23. The 1982 revised criteria for the classification of systemic lupus erythematosus
24. Ophthalmological monitoring of patients taking antimalarials: Preferred practice patterns
25. Ophthalmological monitoring for hydroxychloroquine toxicity: A scientific review of available data